Boston Brain Tumor Ride

Cycling to turn progress into promise

Sunday, May 20, 2018, 200 West St, Waltham, MA

 

The Boston Brain Tumor Rid

The 2018 Boston Brain Tumor Ride, cycling to turn progress into promise, is a can’t-miss fundraising event for cyclists of all levels. All proceeds raised allow National Brain Tumor Society to advance research and public policy, we aim to improve the availability of new and better treatments and fuel the discovery of a cure for brain tumors. This event offers individuals and teams a chance to honor and remember loved ones and connect with others in the brain tumor community.

DATE: Sunday, May 20th, 2018

DISTANCES: 10-mile, 25-mile, 40-mile, 62-mile

New in 2018: Tiered registration fee structure

  • $25 until March 1st
  • $50 until April 15th
  • $75 until May 20th (Day of event registrants welcome!)

FUNDRAISING MINIMUM: $500 (adult participants) $100 (youth participants)

Full Event Details

Fundraising Incentives

Pre-ride events

Volunteer Roles

 

Questions or In need of Assistance Registering?  

Contact your NBTS Staff:

Ashley Brennan:  856.278.3171 – events@braintumor.org

Katie-Rose Crater:  919.323.1922 – events@braintumor.org

 

February 2018

It’s February and the frozen snow that coated the asphalt in January has melted, the conditions have been safe and the open road is calling. OK, maybe the winter weather in New England isn’t your idea of a cyclists dream but that doesn’t mean that your eyes can’t be on our cycling prize.

I’ve been thinking a lot lately about that prize. Our Boston Brain Tumor Ride mantra is pedaling to turn progress into promise and it is the promise that is the prize we are all working towards. The progress that the NBTS has been making happen is remarkable and the promise of new treatments is real and material. Here are a few local highlights:

Dana Farber Cancer Institute

Anti-angiogenic gene therapy for brain tumors

Establishment of a consortium based tissue bank dedicated to Pediatric LGA

Brigham and Women’s Hospital

Defining micro RNA signaling in malignant gliomas.

GM3 as a novel aptoptosis inducing agent for human gliomas

Massachusetts General Hospital

Identification and characterization of novel genetic drivers of glioblastoma

Dendritic cells, onocolytic hsv, and brain tumor immunotherapy

Children’s Hospital Boston

Expression and function of neurotrophins in medulloblastoma

A novel immunotherapeutic strategy for malignant glioma

Harvard University

Allelic variation in carcinogen metabolism and brain tumor risk

These are just a few of the advancements that we, together, have made happen. Our efforts on behalf of the thousands of people who are benefitting from our devotion to the cause is real. It’s genuine and it’s saving lives.

If you haven’t registered for the Boston Brain Tumor Ride the TIME IS NOW!!! Click the link and get on board. While you’re at it, grab a friend and let’s grow this ride to the level that we know it can be! Together we will pedal to turn progress into promise

For Michael Corkin and myself, Co-Chairs, Boston Brain Tumor Ride, and our entire Ride Committee,

May 2018 bring an end to brain tumors.

Love to all,

Steven

Co-Chairs, 2016 Boston Brain Tumor Ride

Pictured Co-Chairs, 2018 Boston Brain Tumor Ride – Steven Branfman and Michael Corkin